Denmark makes national Open Access commitment

November 12, 2004

Denmark has made a nationwide commitment to Open Access for the biomedical research it funds. All universities, hospitals and other research institutes in Denmark became BioMed Central members in October. The membership agreement covers the cost of publication, in BioMed Central's 120 Open Access journals, for all publicly funded researchers and teachers in Denmark.

BioMed Central agreed the membership with the Denmark's Electronic Research Library (DEF) - a co-operation between the Danish research libraries under the Ministry of Science, Technology and Development and the Ministry of Culture.

Bo Öhrström, DEF co-ordinator and deputy director of the Danish National Library Authority, explained why DEF took the decision, "Open Access publications help disseminate research but also represent a completely new development in journal publishing. A national agreement like this benefits all scholars and research institutions in Denmark, including smaller research projects in growth areas."

Natasha Robshaw, Head of Marketing and Sales at BioMed Central, said: "We applaud Denmark's Electronic Research Library for making this important step, and are really excited that three of the four Scandinavian countries have now become BioMed Central members. This will have a huge effect on awareness of Open Access, and its many benefits, in this part of Europe. We hope that Sweden will join its neighbors making a national commitment to Open Access. Sweden has been an early proponent of Open Access- Lund University was the first institution to become a BioMed Central member."

Scandinavia is now leading the world in its commitment to Open Access. Denmark's decision follows an announcement last month that Norway has agreed a national membership with BioMed Central. In May 2004, Finland became the first entire country to sign up for BioMed Central membership for all of its 25000 publicly funded researchers.

BioMed Central

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to